No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HUMA Humacyte
- 8.400
- +1.410+20.17%
Close Jul 15 16:00 ET
- 8.690
- +0.290+3.45%
Pre 04:36 ET
1.00BMarket Cap-8400P/E (TTM)
8.710High7.270Low10.12MVolume7.500Open6.990Pre Close83.12MTurnover12.16%Turnover RatioLossP/E (Static)119.08MShares9.97052wk High38.18P/B698.83MFloat Cap1.96052wk Low--Dividend TTM83.19MShs Float17.450Historical High--Div YieldTTM20.60%Amplitude1.960Historical Low8.213Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Humacyte Shares Are Trading Higher After the Pluristyx Announced a License Agreement With the Company
Humacyte Is Maintained at Buy by BTIG
Humacyte Is Maintained at Buy by
Humacyte Price Target Raised to $11.00/Share From $8.00 by BTIG
Humacyte Price Target Raised to $11.00/Share From $8.00 by
MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index gaining around 250 points on Monday.Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply during Monday's session amid a rise Bitcoin.
(HUMA) - Analyzing Humacyte's Short Interest
Humacyte's (NYSE:HUMA) short percent of float has risen 58.68% since its last report. The company recently reported that it has 8.25 million shares sold short, which is 9.14% of all regular shares
BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Raises Target Price to $11
BTIG analyst Ryan Zimmerman maintains $Humacyte(HUMA.US)$ with a buy rating, and adjusts the target price from $8 to $11.According to TipRanks data, the analyst has a success rate of 47.8% and a
Comments
$Humacyte(HUMA.US$ EMA is crossing up (good), MACD is green and crossed up (good), RSI is over 50 which mean people gonna sale? dont know yet but 50-50. Candle is over BOLL - price might go down a bit then maybe go up again....maybe - put in my watchlist lets see what happen today or tonight or whatever time zone you are in... company financialy is hmmm just ok i guess. 2 giant shark is investing quite interesting. well it just my own analysis.
5
3
$Humacyte(HUMA.US$ 👀clean 10emaX50ma, lift time📊🛫 to 52 high + gainz
3
2
5
$Humacyte(HUMA.US$ $Humacyte(HUMA.US$ finally 9 green days in row , stress free green squeezing zone starting 😎 🆙
7
5
something big going on ,,so my calculated prediction this time also run least 100% considering gradual uptrend in short term I mean few months if can break tons of long term resistance around 11$ish 
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Stoic Trader : Don’t think to much optimize your position size not too big not too much this still has upside up to 14-14.50 easy by maximum 2 to 2.5 month that means buying at $9.97 ( Current support level is approximately $9.97, based on recent price consolidations and breakout
attempts) you got still 5$/share profit , technical buy signal just begun from today market cap just reached 1BUSD from 700MUSD within few days don’t miss upswing volatility , here is my support
Paul bin Anthony : very helpful thanks
Stoic Trader Paul bin Anthony: This got some potential whooo 50% in 3/4 days , gettin in early and riskable position size optimization is key